|
T.EDT
|
I will gladly join in. The NR is terribly incomplete. No data was provided...
|
|
T.EDT
|
I also wonder how Tomuchinformation could state thant a meeting is happening...
|
|
T.EDT
|
Hi there SWYG, I am starting to understand this post, which is one of your...
|
|
T.EDT
|
EUPHASE study in Italy, 2009: Reduction in mortality from 53% to 32%. Why was...
|
|
T.EDT
|
The 45% is Dr Walker's basis for stating that he was very confident: If...
|
|
T.EDT
|
Well, the only thing I could say in his defense (and I am not the least...
|
|
T.EDT
|
Josh 19, at the moment of the conference, he could not have the official...
|
|
T.EDT
|
Can only agree. More on the numbers shortly.
|
|
T.EDT
|
I would certainly be interested in it, if there were grounds for action and...
|
|
T.EDT
|
Could it be that they combined the 176 patient group with those that fit the...
|
|
T.EDT
|
I cannot see it right now, but it matches what he said in his conference...
|
|
T.EDT
|
The 14.5% may be noise, but a very unusual noise. A noise no one in the...
|
|
T.EDT
|
Oui, mais l'effet placebo a t bien trop extraordinaire pour le groupe...
|
|
T.EDT
|
Yes, greatest placebo of all time. Is the 62% representative of other MODS 9...
|
|
T.EDT
|
Mortality of patients non-randomized because no consent form signed...
|
|
T.EDT
|
I have four organs failing right now...
|
|
T.EDT
|
For me, this means this is the best benefit they could find when looking at...
|
|
T.EDT
|
No, 5% mortality benefit would certainly not mean 5% for the placebo. Benefit...
|
|
T.EDT
|
Not enough info to deduct anything good. Failed to meet the end point. 5% for...
|
|
T.EDT
|
This does not match at all what we were told this summer.
|